Kiran Nistala

Kiran Nistala

Chief Medical Officer and Head of DevelopmentatZura Bio· In proxies 2023–2025

Pay in FY2025-60% from the year before · Zura Bio stock +109.6% the same year

Kiran Nistala was paid $1.0M in FY2025 (Dec), down 60%. Zura Bio stock rose 109.6% that year.

Pay$100 in the stock at the end of FY23 → $112
Pay is from the Summary Compensation Table of each Zura Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zura BioPublic company · 3 yr
    • Chief Medical Officer and Head of Development2023 – Present · 3 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?